Liu, Jiaqi
,
Zhou, Yangzhong
Liu, Sen
Song, Xiaofei
Yang, Xin-Zhuang
Fan, Yanhui
Chen, Weisheng
Akdemir, Zeynep Coban
Yan, Zihui
Zuo, Yuzhi
Du, Renqian
Liu, Zhenlei
Yuan, Bo
Zhao, Sen
Liu, Gang
Chen, Yixin
Zhao, Yanxue
Lin, Mao
Zhu, Qiankun
Niu, Yuchen
Liu, Pengfei
Ikegawa, Shiro
Song, You-Qiang
Posey, Jennifer E.
Qiu, Guixing
Zhang, Feng
Wu, Zhihong
Lupski, James R.
Funding for this research was provided by:
National Natural Science Foundation of China (81501852, 81472046, 81772299, 81472045, 81772301)
Beijing Natural Science Foundation (7172175)
Beijing Nova Program (Z161100004916123)
Beijing Nova Program Interdisciplinary Collaborative Project (xxjc201717)
2016 Milstein Medical Asian American Partnership Foundation Fellowship Award in Translational Medicine
The Central Level Public Interest Program for Scientific Research Institute (2016ZX310177)
PUMC Youth Fund & the Fundamental Research Funds for the Central Universities (3332016006)
CAMS Initiative Fund for Medical Sciences (2016-I2M-3-003, 2016-I2M-2-006, 2017-I2M-2-001)
the Distinguished Youth Foundation of Peking Union Medical College Hospital (JQ201506)
the 2016 PUMCH Science Fund for Junior Faculty (PUMCH-2016-1.1)
National Institute of Neurological Disorders and Stroke (NINDS R01NS058529, R35NS105078)
National Human Genome Research Institute (NHGRI/NHLBI UM1 HG006542, NHGRI K08 HG008986)
Article History
Received: 18 March 2018
Accepted: 7 July 2018
First Online: 17 July 2018
Compliance with ethical standards
:
: J.R.L. has stock ownership in 23andMe and Lasergen, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor on multiple the United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered in the Baylor Genetics Laboratory (ExternalRef removed).